Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008
- 961 Downloads
Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD.
KeywordsAutism Asperger syndrome Pervasive developmental disorder Medication Health disparity
This study was supported by Autism Speaks. The funder had no role in determining content. We thank Ms. Teresa Foden for proofreading the manuscript. We gratefully acknowledge the contributions of IAN families, without which this research would not be possible.
- American Society of Health System Pharmacists. (2006). AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists.Google Scholar
- American Psychiatric Association. (2000). Disorders usually first diagnosed in infancy, childhood, or Adolescence. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (Fourth, Text Revision ed.). Arlington, VA: American Psychiatric Association. doi: 10.1176/appi.books.9780890423349.
- Best, S. J., & Krueger, B. S. (2004). Internet data collection. Thousand Oaks, CA: Sage.Google Scholar
- Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry (Revue Canadienne De Psychiatrie), 48(8), 506–516.Google Scholar
- Farmer, J. E., Marvine, A., Law, K., & Anderson, C. (2009). The impact of urbanicity on diagnosis and treatment of ASD. Presented at IMFAR, Chicago, IL.Google Scholar
- Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Jr, Dawson, G., et al. (2000). Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology, 55(4), 468–479.PubMedGoogle Scholar
- Hewson, C., Yule, P., Laurent, D., & Vogel, C. (2003). Internet research methods: A practical guide for the social and behavioral sciences. London: Sage.Google Scholar
- Jones, S., & Fox, S. (2009) Generations online in 2009. Pew Internet and American life project. http://www.pewinternet.org/Reports/2009/Generations-Online-in-2009. Accessed May 20, 2009.
- Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002). Datapoints: Use of multiple psychotropic drugs by medicaid-insured and privately insured children. Psychiatric Services (Washington, D.C.), 53(12), 1508.Google Scholar
- National Center for Health Statistics. (2006) NCHS urban–rural classification scheme for counties. Retrieved November 15, 2008, from http://www.cdc.gov/nchs/r&d/rdc_urbanrural.htm.
- Safer, D. J., Zito, J. M., & Gardner, J. F. (2004). Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services (Washington, D.C.), 55(9), 1049–1051.Google Scholar
- US Census Bureau. (2008). Retrieved October 31, 2008, from http://factfinder.census.gov.
- Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services (Washington, D.C.), 56(2), 157–163.Google Scholar